Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US4781601046
Ticker JNJ
Company JOHNSON & JOHNSON
Currency $
Price
Aware Investor Index (AII) 4.7110
Recommendation BUY
P/E 27.62
ROE 17.70 %
Capitalization 347,758,827,000 $
Dividend Yield 2.39 %
P/S 4.96
AII Position 141
P/E Position 349
ROE Position 196
Capitalization Position 9
Dividend Yield Position 268
Sales 70,074,000,000 $
10-Year Average Earnings 12,592,700,000 $
Shares Outstanding 2,812,900,000
Equity 71,150,000,000 $
Dividend per Share 2.95 $
Industry Personal Care
Country United States
JOHNSON & JOHNSON Investor Relations Web Site http://www.investor.jnj.com/investor-relations.cfm







Sales:

YEAR MONTH AMOUNT
2015 12 70,074,000,000.00 $
2014 12 74,331,000,000.00 $
2013 12 71,312,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 15,409,000,000.00 $
2014 12 16,323,000,000.00 $
2013 12 13,831,000,000.00 $
2012 12 10,514,000,000.00 $
2011 12 9,672,000,000.00 $
2010 12 13,334,000,000.00 $
2009 12 12,266,000,000.00 $
2008 12 12,949,000,000.00 $
2007 12 10,576,000,000.00 $
2006 12 11,053,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 71,150,000,000.00 $
2014 12 69,752,000,000.00 $
2013 12 74,053,000,000.00 $
2012 12 64,826,000,000.00 $
2011 12 57,080,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 2,812,900,000
2014 12 2,863,900,000
2013 12 2,877,000,000
2012 12 2,812,600,000
2011 12 2,775,300,000

 












Bloomberg News for JOHNSON & JOHNSON:

Aug 4, 2010
Arbitrage Profit in U.S. Takeovers Pending on Aug. 4
09/30/10 BSMD US MMSI US 4.38 4.35 0.03 0.69 30,433 Cash 09/30/10 MEND US JNJ US 23.40 23.24 0.16 0.69 168,901 Cash 12/31/10 ODSY US GTIV US 27.00 ...
Jan 3, 2011
U.S. Stock Options With Biggest Changes in Implied Volatility
Volume ============================================================================= JNJ JOHNSON&JOH JNJ US 02/19/11 P65 159.3 16.3 2.72 -23.4 2170 IWM ISHARES-RUS IWM US 01/22/11...
Jan 25, 2011
U.S. Stock Options With Biggest Changes in Implied Volatility
320 JNJ JOHNSON&JOH JNJ US 02/19/11 C60 -17.9 14.0 1.48 -43.1 5406 UNG US NAT GAS UNG US 02/19/11 C5 -17.8 38.2 1.12 -9.7 1068 JNJ JOHNSON&JOH JNJ US 02/19/11...
Aug 11, 2011
Traxis Partners Holdings in 2nd Quarter: 13F Alert
Inc-Class A VMW US 15,868,414 158,320 57,060 Johnson & Johnson JNJ US 15,041,902 226,126 120,000 iShares MSCI Emerging Mkt In EEM US 14,820...
Jul 19, 2011
Midmorning Positive EPS Surprises for U.S. Companies, July 19
21.5 0.92 4.3 Jun KNL KNOLL INC 0.28 0.17 64.7 0.27 3.7 Jun JNJ* JOHNSON&JOHNSON 1.28 1.21 5.8 1.24 3.2 Jun AOS SMITH (A.O.)CORP ...
Mar 17, 2011
Takeda's Deborah Dunsire Is Taking on Cancer
took charge. Takeda expects sales of Velcade, marketed in partnership with Johnson & Johnson (JNJ), to grow 15 percent in fiscal 2011 and double digits again next year. Dunsire...
Feb 14, 2011
Harbert Management Largest Holdings in 4th Quarter: 13F Alert
Digital Corp WDC US 9,417,827 277,812 27,812 Johnson & Johnson JNJ US 9,306,075 150,462 30,462 Pfizer Inc PFE US 9,120...
May 16, 2011
New York State Teachers Holdings in 1st Quarter: 13F Alert
Gamble Co/The PG US -40,782,846 8,198,472 -286,041 Johnson & Johnson JNJ US -39,146,332 7,855,419 -302,704 SOURCE: SEC 13F-HR FILER: New York State Teachers...
Jan 25, 2011
Altera, DeVry, Juniper, RF Micro, Stryker: U.S. Equity Preview
Gilead’s Truvada with Johnson & Johnson’s experimental drug TMC278. Shares of Johnson & Johnson (JNJ US) fell 0.3 percent to $34.26. Juniper Networks Inc. (JNPR US) slipped 1.6 percent to $34.26. ...
Jul 22, 2008
Big Pharma: What Safe Haven?
Is anything in this sector truly safe? Analysts recommend companies such as Johnson & Johnson (JNJ) and Abbott Laboratories (ABT), which are diversified well beyond prescription drugs. On July 15...


Google News for JOHNSON & JOHNSON:

Seeking Alpha - 2 days ago
A 'Tidal Wave' Of Lawsuits Facing Johnson & Johnson Due To The ...
In March, we mentioned the opioid crisis risk for JNJ but also noted that Portfolio Armor estimated a potential return of 6.7% for the stock over ...
CNBC - 2 days ago
Johnson & Johnson CEO to stay on Trump's advisory council to ...
Johnson & Johnson's CEO said Tuesday that he will remain part of Trump's American Manufacturing Council. The executive condemned ...
STAT
Johnson & Johnson (JNJ) Is Rising But Watch The Charts And Be ...
With all other things going on, Johnson & Johnson (NYSE:JNJ) has been on a run — rising 4.78 percent in just three months. It looks like ...
PharmaLive (press release) (subscription)
Johnson & Johnson: After Rising 15% This Year, What's Next?
Johnson & Johnson's (JNJ) cardiology business is struggling. Despite that, the company indicated that it's unlikely to be involved in any M&A ...
USA Commerce Daily - 5 hours ago
Johnson & Johnson Shares Strong Since Actelion Acquisition, But ...
Johnson & Johnson (NYSE: JNJ) shares are up about 20 percent since the company acquired Actelion back in January. However, despite the ...
TopChronicle
Volume Moving the Tape For Shares of Johnson & Johnson (JNJ ...
Needle moving action has been spotted in Johnson & Johnson (JNJ) as shares are moving today on volatility -0.84% or -1.13 from the open.
Week Herald
BTIG Upgrades Masimo Corp. (MASI) to Buy, Johnson & Johnson ...
(MASI) to Buy, Johnson & Johnson (JNJ) Makes Sense As A Buyer ... The analyst comments on a possible MASI acquisition: "JNJ would make ...
High Point Observer
Johnson & Johnson Shares Might Break Lower Before They Break Out
Just a day after Credit Suisse reinstated an Outperform rating on Johnson & Johnson (NYSE: JNJ) based on future gain from Actelion, BTIG and ...
Seeking Alpha - 3 days ago
Jamie Dimon on Trump: 'It is a leader's role ... to bring people ...
Officials from J&J, GE and United Technologies announced their ... CEO of Johnson & Johnson, and the CEO of United Technologies, Gregory ...
Benzinga - 20 Jul 2017
Johnson & Johnson (JNJ) Needle Moving on Volume
Shares of Johnson & Johnson (JNJ) is moving on volatility today -0.51% or -0.69 from the open. The NYSE listed company saw a recent bid of ...


Back